Showing 1 posts of 1 posts found.
Celgene has shelled out $600m for Swiss biotech EngMab in an effort to reinforce its blood cancer portfolio with a …
Weber is new CMO at Sensorion
Charity commits £800,000 to AI research into late breast cancer recurrence
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
Acumetis CEO Herspiegel steps down as Burden assumes role
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia